National Cancer Institute (NCI): Autoimmune Diseases trials
The registry lists 10 Autoimmune Diseases studies with National Cancer Institute (NCI) as lead sponsor. 4 are open to participants now and 1 have results posted.
Phase 1 1Phase 2 6No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) SyndromeRecruitingNCT05027945Phase 2
- Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of ImmunityRecruitingNCT04339777Phase 2
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 1
- Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary ImmunodeficienciesRecruitingNCT02579967Phase 2
- Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or DysregulationActive, not recruitingNCT03663933Phase 2Results posted
- Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell LymphomaActive, not recruitingNCT03922724Phase 2
- Genetic Analysis of Psoriasis and Psoriatic ArthritisCompletedNCT00341809
- Continuation of Follow-up of DES-Exposed CohortsCompletedNCT00340600
- Micellar Paclitaxel to Treat Severe PsoriasisCompletedNCT00006276Phase 2
- Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and CancerCompletedNCT00001582